We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+13.42%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$259M
AUM Growth
-$89.4M
Cap. Flow
-$130M
Cap. Flow %
-50.25%
Top 10 Hldgs %
30.79%
Holding
94
New
15
Increased
16
Reduced
26
Closed
29

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$8.83M
2
MLM icon
Martin Marietta Materials
MLM
+$4.82M
3
ASIX icon
AdvanSix
ASIX
+$4.5M
4
ELV icon
Elevance Health
ELV
+$3.51M
5
BLUE
bluebird bio
BLUE
+$2.9M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$17.8M
2
ALGN icon
Align Technology
ALGN
+$7.72M
3
LOXO
Loxo Oncology, Inc
LOXO
+$4.14M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$4.09M
5
ALB icon
Albemarle
ALB
+$3.95M

Sector Composition

Rank Sector Weight
1 Healthcare 32.38%
2 Technology 17.21%
3 Communication Services 14.84%
4 Consumer Discretionary 6.43%
5 Financials 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGNX
51
DELISTED
Zogenix, Inc.
ZGNX
$2.16M 0.84%
54,000
+14,000
+35% +$538K
JPM icon
52
JPMorgan Chase
JPM
$940B
$2.14M 0.83%
+20,000
New +$2.03M
RGNX icon
53
Regenxbio
RGNX
$655M
$2M 0.77%
60,000
+30,000
+100% +$904K
CGNX icon
54
Cognex
CGNX
$10.7B
$1.96M 0.76%
32,000
-38,000
-54% -$2.42M
VRTX icon
55
Vertex Pharmaceuticals
VRTX
$121B
$1.8M 0.7%
+12,000
New +$1.78M
FWONK icon
56
Liberty Media Series C
FWONK
$25B
$1.71M 0.66%
51,714
– –
HRTX icon
57
Heron Therapeutics
HRTX
$96.3M
$1.63M 0.63%
90,000
– –
LKFT
58
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$1.45M 0.56%
15,500
-30,500
-66% -$2.89M
MRNS
59
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.22M 0.47%
+37,500
New +$1.01M
ALKS icon
60
Alkermes
ALKS
$8.3B
$1.15M 0.44%
21,000
– –
MAC icon
61
Macerich
MAC
$7.27B
$1.12M 0.43%
+17,000
New +$1.04M
TRIP icon
62
CALL
TripAdvisor
TRIP
$1.66B
$1.11M 0.43%
20,000
– –
SAGE
63
DELISTED
Sage Therapeutics
SAGE
$988K 0.38%
+6,000
New +$582K
SGI
64
CALL
Somnigroup International
SGI
$14B
$941K 0.36%
60,000
– –
GHDX
65
CALL
DELISTED
Genomic Health, Inc.
GHDX
$582K 0.23%
+17,000
New +$542K
AAL icon
66
CALL
American Airlines Group
AAL
$10.3B
– –
-82,000
Closed -$3.9M
ACHC icon
67
Acadia Healthcare
ACHC
$2.65B
– –
-59,000
Closed -$2.82M
ALB icon
68
Albemarle
ALB
$13.8B
– –
-29,000
Closed -$3.95M
BIDU icon
69
Baidu
BIDU
$37B
– –
-15,000
Closed -$3.71M
CNC icon
70
Centene
CNC
$30.3B
– –
-44,926
Closed -$2.17M
DBVT
71
DBV Technologies
DBVT
$811M
– –
-2,000
Closed -$848K
EXEL icon
72
Exelixis
EXEL
$14B
– –
-50,000
Closed -$1.21M
HCA icon
73
PUT
HCA Healthcare
HCA
$85B
– –
-60,000
Closed -$4.78M
IRTC icon
74
iRhythm Holdings
IRTC
$3.88B
– –
-61,500
Closed -$3.19M
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$16.2B
– –
-14,500
Closed -$2.12M
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Atika Capital Management held 94 positions worth $259M, down 26% from $348M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Atika Capital Management withdrew a net $130M in Q4 2017, closing 29 positions and reducing 26 holdings. Its most notable exit was Loxo Oncology, Inc, an estimated $4.14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Atika Capital Management opened a new position in Goldman Sachs worth $9.17M.

  • Atika Capital Management's largest Q4 2017 buy was Goldman Sachs: 36,000 shares worth $9.17M.
  • Atika Capital Management added most to Martin Marietta Materials in Q4 2017, an estimated $4.82M increase.
  • Atika Capital Management's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $17.8M.
  • Atika Capital Management fully exited Loxo Oncology, Inc in Q4 2017, selling an estimated $4.14M.
  • Atika Capital Management's ten largest holdings make up 31% of its $259M portfolio in Q4 2017.
  • Atika Capital Management opened 15 new positions and closed 29 in Q4 2017.
  • Atika Capital Management's portfolio value fell 26% quarter-over-quarter to $259M.

Based on Atika Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.